ArthroCare mulls over strategic options
This article was originally published in Clinica
Executive Summary
Minimally-invasive surgical products manufacturer ArthroCare is considering strategic and financial alternatives to boost its shareholder value. The company will work with investment management firm Goldman Sachs to evaluate ways to enhance the company's current stock price.